Related Experiment Video
Updated: May 10, 2026

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
Spirometry evaluation in patient with tuberculosis sequelae treated by lobectomy
Elias Amorim1, Roberto Saad, Roberto Stirbulov
1University Hospital, Federal University of Maranhão, Presidente Dutra, Maranhao State, Brazil. amorimelm@gmail.com
Objective:
To evaluate pre and post-operative spirometry in patients with tuberculosis sequelae undergoing lobectomy.
Methods:
We selected 20 patients, aged between 15 and 56 years, of both genders, with a history of tuberculosis treatment, with repeated infections or hemoptysis and indication of pulmonary lobectomy. The tuberculosis treatment time was six months, and onset of symptoms, between one and 32. We evaluated and compared vital capacity (VC), forced vital capacity (FVC), forced expiratory volume (FEV1), the FEV1/FVC, forced expiratory flow (FEF) and peak expiratory flow (PEF) preoperatively and after the first, third and sixth postoperative months (POM). The significance level (á) used in all tests was 5%, ie, it was considered significant when p <0.05.
Results:
The averages found were: Vital Capacity (VC) - Preoperative: 2.83; 1st POM: 2.12; 3rd POM: 2.31; 6th POM: 2.43. Forced Vital Capacity (FVC) - Preoperative: 2.97; 1st POM: 2.21; 3rd POM: 2.35; 6th POM: 2.53. Expiratory Volume in 1 second (FEV1) - Preoperative: 2.23; 1st POM: 1.75; 3rd POM: 1.81; 6th POM 1.97. There was marked decrease in lung function in the first month after surgery, but there was an improvement of the parameters from the third month, with gradual increase up to the sixth month.
Conclusion:
There was no recovery of preoperative spirometric parameters at six months postoperatively in patients with sequelae of tuberculosis submitted to lobectomy.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Management Using Bronchodilators and Corticosteroids
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
